12.80
price up icon0.39%   0.05
after-market After Hours: 12.40 -0.40 -3.13%
loading

Ars Pharmaceuticals Inc Stock (SPRY) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - 0.01 0.02
Operating Expenses
29.00%
13.19
10.23 17.98 20.61 18.73
Operating Income/Loss
29.00%
-13.19
-10.23 -17.98 -20.60 -18.71
Income/Loss From Continuing Operations Before Tax
-10.29
- -14.87 0.01 0.02
Income/Loss From Continuing Operations After Tax
43.58%
-10.29
-7.168 -14.87 -17.37 -14.96
Net Income/Loss
43.58%
-10.29
-7.168 -14.87 -17.37 -14.96
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
31,503%
96.49
0.3053 95.58 94.91 94.23
Diluted Average Shares
31,503%
96.49
0.3053 95.58 94.91 94.23
Basic Earnings Per Share
57.14%
-0.11
-0.07 -0.16 -0.18 -0.16
Diluted Earnings Per Share
57.14%
-0.11
-0.07 -0.16 -0.18 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):